Two year outcomes in a study comparing transcatheter to surgical bioprosthetic aortic valve implantation, shows that the less invasive procedure is safe and effective, and comparable to the gold standard, surgical valve replacement, in patients whose operational risk was lower than that of patients studied in the pivotal randomized trials for these newer devices.

Source: Heart surgery? TAVI, safe and effective as surgical valves at 2 years in lower risk patients


David Cottle

UBB Owner & Administrator